Edgewise Therapeutics Inc. (EWTX) NASDAQ
$17.80 (0.16) (-0.89%)
Market Cap: $1.67B
As of 03/28/24 02:09 PM EDT. Market open.
Edgewise Therapeutics Inc. (EWTX)
NASDAQ
$17.80
(0.16) (-0.89%)
Market Cap: $1.67B
As of 03/28/24 02:09 PM EDT. Market open.
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from ... read more
edgewise therapeutics is a biotechnology company focused on developing novel therapies for diseases involving skeletal muscle. the company is headquartered in boulder, co and received its series a financing from orbimed. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
MOORE JOHN R | General Counsel | Feb 07, 2024 | Option Exercise | $1.93 | 17,993 | 34,726 | 17,993 | Feb 09, 2024, 05:43 PM |
MOORE JOHN R | General Counsel | Feb 09, 2024 | Option Exercise | $1.93 | 8,029 | 15,496 | 8,029 | Feb 09, 2024, 05:43 PM |
MOORE JOHN R | General Counsel | Feb 08, 2024 | Option Exercise | $1.93 | 3,813 | 7,359 | 3,813 | Feb 09, 2024, 05:43 PM |
MOORE JOHN R | General Counsel | Feb 07, 2024 | Sale | $20.00 | 17,993 | 359,864 | 0 | Feb 09, 2024, 05:43 PM |
MOORE JOHN R | General Counsel | Feb 09, 2024 | Sale | $20.01 | 8,029 | 160,657 | 0 | Feb 09, 2024, 05:43 PM |
MOORE JOHN R | General Counsel | Feb 08, 2024 | Sale | $20.01 | 3,813 | 76,285 | 0 | Feb 09, 2024, 05:43 PM |
Derakhshan Behrad | Chief Business Officer | Feb 07, 2024 | Option Exercise | $1.93 | 600 | 1,158 | 7,620 | Feb 09, 2024, 05:42 PM |
Derakhshan Behrad | Chief Business Officer | Feb 09, 2024 | Option Exercise | $1.93 | 4,800 | 9,264 | 11,820 | Feb 09, 2024, 05:42 PM |
Derakhshan Behrad | Chief Business Officer | Feb 08, 2024 | Option Exercise | $1.93 | 4,600 | 8,878 | 11,620 | Feb 09, 2024, 05:42 PM |
Derakhshan Behrad | Chief Business Officer | Feb 07, 2024 | Sale | $20.00 | 600 | 12,000 | 7,020 | Feb 09, 2024, 05:42 PM |
Derakhshan Behrad | Chief Business Officer | Feb 09, 2024 | Sale | $20.04 | 4,800 | 96,209 | 7,020 | Feb 09, 2024, 05:42 PM |
Derakhshan Behrad | Chief Business Officer | Feb 08, 2024 | Sale | $20.01 | 4,600 | 92,049 | 7,020 | Feb 09, 2024, 05:42 PM |
Carruthers R Michael | Chief Financial Officer | Jan 23, 2024 | Option Exercise | $1.93 | 90,000 | 173,700 | 119,024 | Jan 25, 2024, 04:46 PM |
Carruthers R Michael | Chief Financial Officer | Jan 23, 2024 | Sale | $15.78 | 90,000 | 1,419,759 | 29,024 | Jan 25, 2024, 04:46 PM |
Thompson Peter A. | Director | Jan 23, 2024 | Buy | $11.00 | 454,545 | 4,999,995 | 14,436,497 | Jan 25, 2024, 04:32 PM |
ORBIMED ADVISORS LLC | Director | Jan 23, 2024 | Buy | $11.00 | 454,545 | 4,999,995 | 14,436,497 | Jan 25, 2024, 04:28 PM |
Fox Jonathan C | Director | Dec 26, 2023 | Buy | $9.30 | 10,857 | 100,958 | 10,857 | Dec 28, 2023, 04:39 PM |
MOORE JOHN R | General Counsel | Dec 27, 2023 | Sale | $10.50 | 8,497 | 89,219 | 0 | Dec 28, 2023, 04:39 PM |
Russell Alan J | Chief Scientific Officer | Dec 26, 2023 | Sale | $9.33 | 172,585 | 1,610,097 | 3,606 | Dec 28, 2023, 04:38 PM |
Carruthers R Michael | Chief Financial Officer | Jun 22, 2023 | Option Exercise | $0.71 | 10,000 | 7,100 | 29,024 | Jun 26, 2023, 04:28 PM |
Derakhshan Behrad | Chief Business Officer | May 02, 2023 | Sale | $8.90 | 1,747 | 15,557 | 7,020 | May 03, 2023, 06:26 PM |
MOORE JOHN R | General Counsel | May 02, 2023 | Sale | $8.90 | 1,897 | 16,893 | 6,565 | May 03, 2023, 06:26 PM |
Carruthers R Michael | Chief Financial Officer | May 02, 2023 | Sale | $8.90 | 1,336 | 11,897 | 16,126 | May 03, 2023, 06:26 PM |
Russell Alan J | Chief Scientific Officer | May 02, 2023 | Sale | $8.90 | 1,602 | 14,266 | 176,191 | May 03, 2023, 06:26 PM |
Donovan Joanne M. | CMO | May 02, 2023 | Sale | $8.90 | 3,254 | 28,977 | 9,960 | May 03, 2023, 06:25 PM |
KOCH KEVIN | President and CEO | May 02, 2023 | Sale | $8.90 | 3,203 | 28,522 | 7,213 | May 03, 2023, 06:25 PM |
MOORE JOHN R | General Counsel | Oct 03, 2022 | Option Exercise | $1.93 | 4,730 | 9,129 | 7,730 | Oct 05, 2022, 04:42 PM |
MOORE JOHN R | General Counsel | Oct 03, 2022 | Sale | $9.76 | 4,730 | 46,155 | 3,000 | Oct 05, 2022, 04:42 PM |
Thompson Peter A. | Director | Sep 16, 2022 | Buy | $10.32 | 484,496 | 4,999,999 | 13,981,952 | Sep 16, 2022, 04:34 PM |
ORBIMED ADVISORS LLC | Director | Sep 16, 2022 | Buy | $10.32 | 484,496 | 4,999,999 | 13,981,952 | Sep 16, 2022, 04:31 PM |
Novo Holdings A/S | 10% Owner | Sep 14, 2022 | Buy | $10.32 | 484,496 | 4,999,999 | 6,071,703 | Sep 16, 2022, 02:35 PM |
MOORE JOHN R | General Counsel | Sep 06, 2022 | Option Exercise | $1.93 | 4,730 | 9,129 | 7,730 | Sep 08, 2022, 04:16 PM |
MOORE JOHN R | General Counsel | Sep 06, 2022 | Sale | $10.91 | 4,730 | 51,598 | 5,351 | Sep 08, 2022, 04:16 PM |
MOORE JOHN R | General Counsel | Aug 03, 2022 | Option Exercise | $1.34 | 9,232 | 12,325 | 12,232 | Aug 05, 2022, 04:12 PM |
MOORE JOHN R | General Counsel | Aug 03, 2022 | Sale | $9.31 | 9,232 | 85,921 | 3,000 | Aug 05, 2022, 04:12 PM |
MOORE JOHN R | General Counsel | Jul 06, 2022 | Option Exercise | $1.93 | 1,046 | 2,019 | 4,046 | Jul 07, 2022, 04:23 PM |
MOORE JOHN R | General Counsel | Jul 05, 2022 | Option Exercise | $1.26 | 8,186 | 10,307 | 11,186 | Jul 07, 2022, 04:23 PM |
MOORE JOHN R | General Counsel | Jul 05, 2022 | Sale | $8.35 | 8,186 | 68,329 | 3,000 | Jul 07, 2022, 04:23 PM |
MOORE JOHN R | General Counsel | Jul 06, 2022 | Sale | $8.54 | 1,046 | 8,928 | 3,000 | Jul 07, 2022, 04:23 PM |
MOORE JOHN R | General Counsel | Jun 16, 2022 | Option Exercise | $1.93 | 14,722 | 28,413 | 17,722 | Jun 21, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Jun 21, 2022 | Option Exercise | $1.40 | 31,078 | 43,501 | 34,078 | Jun 21, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Jun 17, 2022 | Option Exercise | $1.93 | 22,127 | 42,705 | 25,127 | Jun 21, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Jun 16, 2022 | Sale | $6.17 | 14,722 | 90,805 | 3,000 | Jun 21, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Jun 21, 2022 | Sale | $7.29 | 31,078 | 226,695 | 3,000 | Jun 21, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Jun 17, 2022 | Sale | $6.62 | 22,127 | 146,434 | 3,000 | Jun 21, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Jun 13, 2022 | Option Exercise | $0.71 | 4,093 | 2,906 | 7,093 | Jun 15, 2022, 06:39 PM |
MOORE JOHN R | General Counsel | Jun 15, 2022 | Option Exercise | $0.75 | 18,660 | 13,962 | 21,660 | Jun 15, 2022, 06:39 PM |
MOORE JOHN R | General Counsel | Jun 14, 2022 | Option Exercise | $0.71 | 3,628 | 2,576 | 6,628 | Jun 15, 2022, 06:39 PM |
MOORE JOHN R | General Counsel | Jun 13, 2022 | Sale | $6.01 | 4,093 | 24,582 | 3,000 | Jun 15, 2022, 06:39 PM |
MOORE JOHN R | General Counsel | Jun 15, 2022 | Sale | $6.11 | 18,660 | 114,020 | 21,075 | Jun 15, 2022, 06:39 PM |
MOORE JOHN R | General Counsel | Jun 14, 2022 | Sale | $6.02 | 3,628 | 21,855 | 3,000 | Jun 15, 2022, 06:39 PM |
MOORE JOHN R | General Counsel | Jun 08, 2022 | Option Exercise | $0.71 | 12,566 | 8,922 | 15,566 | Jun 10, 2022, 06:34 PM |
MOORE JOHN R | General Counsel | Jun 10, 2022 | Option Exercise | $0.71 | 7,125 | 5,059 | 10,125 | Jun 10, 2022, 06:34 PM |
MOORE JOHN R | General Counsel | Jun 09, 2022 | Option Exercise | $0.71 | 7,615 | 5,407 | 10,615 | Jun 10, 2022, 06:34 PM |
MOORE JOHN R | General Counsel | Jun 10, 2022 | Sale | $6.05 | 7,125 | 43,120 | 3,000 | Jun 10, 2022, 06:34 PM |
MOORE JOHN R | General Counsel | Jun 09, 2022 | Sale | $6.49 | 7,615 | 49,397 | 3,000 | Jun 10, 2022, 06:34 PM |
MOORE JOHN R | General Counsel | Jun 08, 2022 | Sale | $6.63 | 12,566 | 83,362 | 3,000 | Jun 10, 2022, 06:34 PM |
MOORE JOHN R | General Counsel | Jun 03, 2022 | Option Exercise | $1.93 | 15,230 | 29,394 | 18,230 | Jun 07, 2022, 07:03 PM |
MOORE JOHN R | General Counsel | Jun 07, 2022 | Option Exercise | $0.78 | 18,123 | 14,054 | 20,150 | Jun 07, 2022, 07:03 PM |
MOORE JOHN R | General Counsel | Jun 06, 2022 | Option Exercise | $1.93 | 13,934 | 26,893 | 16,934 | Jun 07, 2022, 07:03 PM |
MOORE JOHN R | General Counsel | Jun 07, 2022 | Sale | $6.61 | 18,123 | 119,702 | 3,000 | Jun 07, 2022, 07:03 PM |
MOORE JOHN R | General Counsel | Jun 06, 2022 | Sale | $6.03 | 13,934 | 84,085 | 3,000 | Jun 07, 2022, 07:03 PM |
MOORE JOHN R | General Counsel | Jun 03, 2022 | Sale | $6.05 | 15,230 | 92,198 | 3,000 | Jun 07, 2022, 07:03 PM |
Carruthers R Michael | Chief Financial Officer | May 23, 2022 | Option Exercise | $0.71 | 9,000 | 6,390 | 12,000 | May 25, 2022, 06:11 PM |
ORBIMED ADVISORS LLC | Director | May 18, 2022 | Buy | $7.21 | 138,000 | 994,980 | 13,497,456 | May 20, 2022, 04:38 PM |
Thompson Peter A. | Director | May 18, 2022 | Buy | $7.21 | 138,000 | 994,980 | 13,497,456 | May 20, 2022, 04:32 PM |
MOORE JOHN R | General Counsel | May 16, 2022 | Sale | $7.42 | 10,800 | 80,146 | 3,000 | May 18, 2022, 05:15 PM |
MOORE JOHN R | General Counsel | Jan 21, 2022 | Option Exercise | $0.71 | 5,400 | 3,834 | 12,362 | Jan 25, 2022, 06:50 PM |
MOORE JOHN R | General Counsel | Dec 28, 2021 | Option Exercise | $0.71 | 5,400 | 3,834 | 6,962 | Dec 30, 2021, 05:51 PM |
Russell Alan J | Chief Scientific Officer | Nov 30, 2021 | Option Exercise | $0.22 | 172,585 | 37,815 | 172,585 | Dec 01, 2021, 06:20 PM |
Russell Alan J | Chief Scientific Officer | Nov 15, 2021 | Sale | $19.11 | 479 | 9,155 | 38 | Nov 17, 2021, 06:05 PM |
Russell Alan J | Chief Scientific Officer | Nov 12, 2021 | Sale | $19.51 | 8,562 | 167,074 | 479 | Nov 12, 2021, 05:24 PM |
Russell Alan J | Chief Scientific Officer | Nov 11, 2021 | Sale | $19.93 | 19,276 | 384,238 | 12,722 | Nov 12, 2021, 05:24 PM |
Russell Alan J | Chief Scientific Officer | Nov 10, 2021 | Sale | $19.73 | 12,326 | 243,170 | 28,897 | Nov 12, 2021, 05:24 PM |
Russell Alan J | Chief Scientific Officer | Nov 09, 2021 | Sale | $20.09 | 29,576 | 594,306 | 53,355 | Nov 12, 2021, 05:24 PM |
Russell Alan J | Chief Scientific Officer | Nov 08, 2021 | Sale | $20.16 | 9,017 | 181,824 | 70,219 | Nov 08, 2021, 07:11 PM |
Russell Alan J | Chief Scientific Officer | Nov 05, 2021 | Sale | $19.62 | 13,042 | 255,907 | 92,272 | Nov 08, 2021, 07:11 PM |
Russell Alan J | Chief Scientific Officer | Nov 04, 2021 | Sale | $19.76 | 7,392 | 146,092 | 92,278 | Nov 08, 2021, 07:11 PM |
Russell Alan J | Chief Scientific Officer | Nov 03, 2021 | Sale | $18.18 | 26,184 | 476,096 | 105,032 | Nov 03, 2021, 07:00 PM |
Russell Alan J | Chief Scientific Officer | Nov 02, 2021 | Sale | $17.43 | 17,519 | 305,360 | 125,854 | Nov 03, 2021, 07:00 PM |
Russell Alan J | Chief Scientific Officer | Nov 01, 2021 | Sale | $18.02 | 469 | 8,454 | 143,373 | Nov 03, 2021, 07:00 PM |
Russell Alan J | Chief Scientific Officer | Oct 15, 2021 | Sale | $18.12 | 1,433 | 25,966 | 143,968 | Oct 18, 2021, 07:48 PM |
Russell Alan J | Chief Scientific Officer | Oct 14, 2021 | Sale | $18.18 | 5,749 | 104,517 | 145,275 | Oct 18, 2021, 07:48 PM |
Russell Alan J | Chief Scientific Officer | Oct 11, 2021 | Sale | $18.02 | 1,270 | 22,885 | 151,024 | Oct 13, 2021, 06:51 PM |
Russell Alan J | Chief Scientific Officer | Oct 08, 2021 | Sale | $18.15 | 5,902 | 107,121 | 152,294 | Oct 08, 2021, 06:00 PM |
Russell Alan J | Chief Scientific Officer | Oct 07, 2021 | Sale | $18.56 | 13,018 | 241,614 | 158,196 | Oct 08, 2021, 06:00 PM |
Russell Alan J | Chief Scientific Officer | Oct 06, 2021 | Sale | $18.03 | 2,108 | 38,007 | 171,214 | Oct 08, 2021, 06:00 PM |
Russell Alan J | Chief Scientific Officer | Oct 04, 2021 | Sale | $18.00 | 100 | 1,800 | 178,726 | Oct 05, 2021, 06:33 PM |
Russell Alan J | Chief Scientific Officer | Oct 01, 2021 | Sale | $18.00 | 274 | 4,932 | 178,826 | Oct 05, 2021, 06:33 PM |
Russell Alan J | Chief Scientific Officer | Oct 05, 2021 | Sale | $18.26 | 5,404 | 98,677 | 173,322 | Oct 05, 2021, 06:33 PM |
Russell Alan J | Chief Scientific Officer | Sep 29, 2021 | Sale | $16.86 | 11,844 | 199,730 | 179,718 | Sep 30, 2021, 07:16 PM |
Russell Alan J | Chief Scientific Officer | Sep 28, 2021 | Sale | $17.30 | 14,610 | 252,753 | 190,944 | Sep 30, 2021, 07:16 PM |
Russell Alan J | Chief Scientific Officer | Sep 23, 2021 | Sale | $18.54 | 26,835 | 497,632 | 242,337 | Sep 27, 2021, 07:32 PM |
Russell Alan J | Chief Scientific Officer | Sep 27, 2021 | Sale | $17.98 | 11,611 | 208,774 | 205,571 | Sep 27, 2021, 07:32 PM |
Russell Alan J | Chief Scientific Officer | Sep 24, 2021 | Sale | $18.16 | 20,100 | 365,016 | 217,165 | Sep 27, 2021, 07:32 PM |
ROOT JONATHAN D | Director | Mar 30, 2021 | Buy | $16.00 | 15,625 | 250,000 | 15,625 | Mar 31, 2021, 07:12 PM |
Thompson Peter A. | Director | Mar 30, 2021 | Buy | $16.00 | 359,375 | 5,750,000 | 13,359,456 | Mar 31, 2021, 07:11 PM |
ORBIMED ADVISORS LLC | Director | Mar 30, 2021 | Buy | $16.00 | 359,375 | 5,750,000 | 13,359,456 | Mar 31, 2021, 07:10 PM |
Novo Holdings A/S | 10% Owner | Mar 30, 2021 | Buy | $16.00 | 625,000 | 10,000,000 | 5,587,207 | Mar 31, 2021, 04:36 PM |
Flynn James E | 10% Owner | Mar 30, 2021 | Buy | $16.00 | 625,000 | 10,000,000 | 3,933,137 | Mar 30, 2021, 03:42 PM |
Owner | Relationship | Date | Value($) |
MOORE JOHN R | General Counsel | 02/07/2024 | 34,726 |
MOORE JOHN R | General Counsel | 02/09/2024 | 15,496 |
MOORE JOHN R | General Counsel | 02/08/2024 | 7,359 |
MOORE JOHN R | General Counsel | 02/07/2024 | 359,864 |
MOORE JOHN R | General Counsel | 02/09/2024 | 160,657 |
MOORE JOHN R | General Counsel | 02/08/2024 | 76,285 |
Derakhshan Behrad | Chief Business Officer | 02/07/2024 | 1,158 |
Derakhshan Behrad | Chief Business Officer | 02/09/2024 | 9,264 |
Derakhshan Behrad | Chief Business Officer | 02/08/2024 | 8,878 |
Derakhshan Behrad | Chief Business Officer | 02/07/2024 | 12,000 |
Derakhshan Behrad | Chief Business Officer | 02/09/2024 | 96,209 |
Derakhshan Behrad | Chief Business Officer | 02/08/2024 | 92,049 |
Carruthers R Michael | Chief Financial Officer | 01/23/2024 | 173,700 |
Carruthers R Michael | Chief Financial Officer | 01/23/2024 | 1,419,759 |
Thompson Peter A. | Director | 01/23/2024 | 4,999,995 |
ORBIMED ADVISORS LLC | Director | 01/23/2024 | 4,999,995 |
Fox Jonathan C | Director | 12/26/2023 | 100,958 |
MOORE JOHN R | General Counsel | 12/27/2023 | 89,219 |
Russell Alan J | Chief Scientific Officer | 12/26/2023 | 1,610,097 |
Carruthers R Michael | Chief Financial Officer | 06/22/2023 | 7,100 |
Derakhshan Behrad | Chief Business Officer | 05/02/2023 | 15,557 |
MOORE JOHN R | General Counsel | 05/02/2023 | 16,893 |
Carruthers R Michael | Chief Financial Officer | 05/02/2023 | 11,897 |
Russell Alan J | Chief Scientific Officer | 05/02/2023 | 14,266 |
Donovan Joanne M. | CMO | 05/02/2023 | 28,977 |
KOCH KEVIN | President and CEO | 05/02/2023 | 28,522 |
MOORE JOHN R | General Counsel | 10/03/2022 | 9,129 |
MOORE JOHN R | General Counsel | 10/03/2022 | 46,155 |
Thompson Peter A. | Director | 09/16/2022 | 4,999,999 |
ORBIMED ADVISORS LLC | Director | 09/16/2022 | 4,999,999 |
Novo Holdings A/S | 10% Owner | 09/14/2022 | 4,999,999 |
MOORE JOHN R | General Counsel | 09/06/2022 | 9,129 |
MOORE JOHN R | General Counsel | 09/06/2022 | 51,598 |
MOORE JOHN R | General Counsel | 08/03/2022 | 12,325 |
MOORE JOHN R | General Counsel | 08/03/2022 | 85,921 |
MOORE JOHN R | General Counsel | 07/06/2022 | 2,019 |
MOORE JOHN R | General Counsel | 07/05/2022 | 10,307 |
MOORE JOHN R | General Counsel | 07/05/2022 | 68,329 |
MOORE JOHN R | General Counsel | 07/06/2022 | 8,928 |
MOORE JOHN R | General Counsel | 06/16/2022 | 28,413 |
MOORE JOHN R | General Counsel | 06/21/2022 | 43,501 |
MOORE JOHN R | General Counsel | 06/17/2022 | 42,705 |
MOORE JOHN R | General Counsel | 06/16/2022 | 90,805 |
MOORE JOHN R | General Counsel | 06/21/2022 | 226,695 |
MOORE JOHN R | General Counsel | 06/17/2022 | 146,434 |
MOORE JOHN R | General Counsel | 06/13/2022 | 2,906 |
MOORE JOHN R | General Counsel | 06/15/2022 | 13,962 |
MOORE JOHN R | General Counsel | 06/14/2022 | 2,576 |
MOORE JOHN R | General Counsel | 06/13/2022 | 24,582 |
MOORE JOHN R | General Counsel | 06/15/2022 | 114,020 |
MOORE JOHN R | General Counsel | 06/14/2022 | 21,855 |
MOORE JOHN R | General Counsel | 06/08/2022 | 8,922 |
MOORE JOHN R | General Counsel | 06/10/2022 | 5,059 |
MOORE JOHN R | General Counsel | 06/09/2022 | 5,407 |
MOORE JOHN R | General Counsel | 06/10/2022 | 43,120 |
MOORE JOHN R | General Counsel | 06/09/2022 | 49,397 |
MOORE JOHN R | General Counsel | 06/08/2022 | 83,362 |
MOORE JOHN R | General Counsel | 06/03/2022 | 29,394 |
MOORE JOHN R | General Counsel | 06/07/2022 | 14,054 |
MOORE JOHN R | General Counsel | 06/06/2022 | 26,893 |
MOORE JOHN R | General Counsel | 06/07/2022 | 119,702 |
MOORE JOHN R | General Counsel | 06/06/2022 | 84,085 |
MOORE JOHN R | General Counsel | 06/03/2022 | 92,198 |
Carruthers R Michael | Chief Financial Officer | 05/23/2022 | 6,390 |
ORBIMED ADVISORS LLC | Director | 05/18/2022 | 994,980 |
Thompson Peter A. | Director | 05/18/2022 | 994,980 |
MOORE JOHN R | General Counsel | 05/16/2022 | 80,146 |
MOORE JOHN R | General Counsel | 01/21/2022 | 3,834 |
MOORE JOHN R | General Counsel | 12/28/2021 | 3,834 |
Russell Alan J | Chief Scientific Officer | 11/30/2021 | 37,815 |
Russell Alan J | Chief Scientific Officer | 11/15/2021 | 9,155 |
Russell Alan J | Chief Scientific Officer | 11/12/2021 | 167,074 |
Russell Alan J | Chief Scientific Officer | 11/11/2021 | 384,238 |
Russell Alan J | Chief Scientific Officer | 11/10/2021 | 243,170 |
Russell Alan J | Chief Scientific Officer | 11/09/2021 | 594,306 |
Russell Alan J | Chief Scientific Officer | 11/08/2021 | 181,824 |
Russell Alan J | Chief Scientific Officer | 11/05/2021 | 255,907 |
Russell Alan J | Chief Scientific Officer | 11/04/2021 | 146,092 |
Russell Alan J | Chief Scientific Officer | 11/03/2021 | 476,096 |
Russell Alan J | Chief Scientific Officer | 11/02/2021 | 305,360 |
Russell Alan J | Chief Scientific Officer | 11/01/2021 | 8,454 |
Russell Alan J | Chief Scientific Officer | 10/15/2021 | 25,966 |
Russell Alan J | Chief Scientific Officer | 10/14/2021 | 104,517 |
Russell Alan J | Chief Scientific Officer | 10/11/2021 | 22,885 |
Russell Alan J | Chief Scientific Officer | 10/08/2021 | 107,121 |
Russell Alan J | Chief Scientific Officer | 10/07/2021 | 241,614 |
Russell Alan J | Chief Scientific Officer | 10/06/2021 | 38,007 |
Russell Alan J | Chief Scientific Officer | 10/04/2021 | 1,800 |
Russell Alan J | Chief Scientific Officer | 10/01/2021 | 4,932 |
Russell Alan J | Chief Scientific Officer | 10/05/2021 | 98,677 |
Russell Alan J | Chief Scientific Officer | 09/29/2021 | 199,730 |
Russell Alan J | Chief Scientific Officer | 09/28/2021 | 252,753 |
Russell Alan J | Chief Scientific Officer | 09/23/2021 | 497,632 |
Russell Alan J | Chief Scientific Officer | 09/27/2021 | 208,774 |
Russell Alan J | Chief Scientific Officer | 09/24/2021 | 365,016 |
ROOT JONATHAN D | Director | 03/30/2021 | 250,000 |
Thompson Peter A. | Director | 03/30/2021 | 5,750,000 |
ORBIMED ADVISORS LLC | Director | 03/30/2021 | 5,750,000 |
Novo Holdings A/S | 10% Owner | 03/30/2021 | 10,000,000 |
Flynn James E | 10% Owner | 03/30/2021 | 10,000,000 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 14,756,096 | 3.24% | 1.30% | Other |
VIKING GLOBAL INVESTORS LP | 6,159,146 | 0.25% | No change | Growth At A Reasonable Price |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | 0.79% | No change | Other |
BlackRock Inc. | 3,505,199 | 0.00159% | 5.99% | Other |
BAKER BROS. ADVISORS LP | 3,112,786 | 0.39% | 196.54% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 947,046 | 0.00108% | 6.2% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 395,069 | 0.05% | New | Growth |
CANDRIAM S.C.A. | 308,000 | 0.02% | 3.36% | Other |
RENAISSANCE TECHNOLOGIES LLC | 64,700 | 0.0011% | -57.15% | Other |
UBS OCONNOR LLC | 114,685 | 0.09% | -18% | Value |
ALPS ADVISORS INC | 43,226 | 0.00372% | -7.78% | Other |
D. E. SHAW & CO., INC. | 31,950 | 0.00031% | New | Other |
Period of Report: 12/31/2023
10-K/10-Q Filings: View